F19.932
Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code F19.932 pertains to a condition involving the use of unspecified psychoactive substances. It specifically highlights cases where an individual experiences withdrawal symptoms accompanied by perceptual disturbances, such as hallucinations or altered sensory perceptions. This condition underscores the complex nature of substance use disorders, emphasizing the potential for both physical dependence and mental health effects. Recognizing this diagnosis can help health professionals tailor appropriate treatment and support strategies for affected individuals.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of psychoactive substances, such as stimulants, sedatives, or hallucinogens Sudden cessation or reduction of substance intake in dependent individuals History of substance use disorder with inadequate management or treatment Use of an unspecified or unclassified psychoactive drug leading to unpredictable effects Combination of multiple substances raising the risk of withdrawal and perceptual issues
Key Symptoms: Withdrawal symptoms such as sweating, tremors, nausea, or anxiety Perceptual disturbances including hallucinations, illusions, or altered sensory perceptions Restlessness or agitation Difficulty concentrating or disorientation Mood swings or emotional instability Physical symptoms like increased heart rate or blood pressure during withdrawal Potential psychosis or paranoia during perceptual disturbances
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment based on the patient's history of substance use, observing withdrawal signs, and identifying perceptual disturbances. Healthcare providers may utilize questionnaires, physical examinations, and mental health evaluations. In some cases, laboratory tests can assist, but the diagnosis is primarily clinical. Recognizing the specific pattern of symptoms associated with F19.932 helps in planning suitable management strategies and monitoring progress safely.
Treatment Protocols: Management typically includes supervised detoxification to safely manage withdrawal symptoms. Pharmacological interventions may be used to alleviate specific symptoms, such as antipsychotics for severe perceptual disturbances or medications to reduce withdrawal discomfort. Psychosocial support, counseling, and therapy are crucial for addressing underlying behavioral aspects of substance use. Long-term strategies often involve addiction treatment programs, support groups, and relapse prevention plans to sustain recovery and prevent recurrence of symptoms.
Clinical Advice & FAQs
Billing Guidance
Is F19.932 a billable ICD-10 code?
Yes, F19.932 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.932?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance and any associated comorbidities for accurate reporting.
Cite this Clinical Reference